General Information of the Compound
Compound ID
CP0416471
Compound Name
N-(4-propan-2-ylpiperazin-1-yl)-N-(pyrimidin-4-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-amine
    Show/Hide
Structure
Formula
C21H30N6
Molecular Weight
366.513
Canonical SMILES
CC(C)N1CCN(CC1)N(Cc1ccncn1)C1CCCc2cccnc12
    Show/Hide
InChI
InChI=1S/C21H30N6/c1-17(2)25-11-13-26(14-12-25)27(15-19-8-10-22-16-24-19)20-7-3-5-18-6-4-9-23-21(18)20/h4,6,8-10,16-17,20H,3,5,7,11-15H2,1-2H3
    Show/Hide
InChIKey
OXYOGGMFEOPAMV-UHFFFAOYSA-N
Physicochemical Property
logP
2.6922
Rotatable Bonds
5
Heavy Atom Count
27
Polar Areas
48.39
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145972839
ChEMBL ID
CHEMBL4216789
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02059, C-X-C chemokine receptor type 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000571 HPB-ALL Homo sapiens (Human)  1
1
IC50 = 210 nM
   TI
   LI
   LO
   TS